ArticleThe Journal of biological chemistry2018

PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells.

Tasneem Motiwala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.